Daunorubicin (hydrochloride)

Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor[1][2][4][5].

Product Specifications

CAS Number

[23541-50-6]

Product Name Alternative

Daunomycin (hydrochloride) ; RP 13057 (hydrochloride) ; Rubidomycin (hydrochloride)

UNSPSC

12352005

Hazard Statement

H301, H341, H351, H360

Target

ADC Payload; Antibiotic; Apoptosis; Autophagy; Bacterial; DNA/RNA Synthesis; Topoisomerase

Type

Natural Products

Related Pathways

Antibody-drug Conjugate/ADC Related; Anti-infection; Apoptosis; Autophagy; Cell Cycle/DNA Damage

Applications

Cancer-programmed cell death

Field of Research

Cancer; Infection; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/Daunorubicin-Hydrochloride.html

Concentration

10mM

Purity

99.67

Solubility

DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C) |H2O : ≥ 34 mg/mL

Smiles

O=C(C(C(OC)=CC=C1)=C1C2=O)C3=C2C(O)=C(C[C@@](O)(C(C)=O)C[C@@H]4O[C@@]5([H])C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O.[H]Cl

Molecular Formula

C27H30ClNO10

Molecular Weight

563.98

Precautions

H301, H341, H351, H360

References & Citations

[1]Lehmann M, et al. Activity of topoisomerase inhibitors daunorubicin, idarubicin, and aclarubicin in the Drosophila Somatic Mutation and Recombination Test. Environ Mol Mutagen. 2004;43 (4) :250-7.|[2]Svensson SP, et al. Melanin inhibits cytotoxic effects of Doxorubicin and Daunorubicin in MOLT 4 cells. Pigment Cell Res. 2003 Aug;16 (4) :351-4|[3]Gervasoni JE Jr, et al. An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and Daunorubicin by induction of both necrosis and apoptosis. Anticancer Res. 2004 Sep-Oct;24 (5A) :2617-26|[4]Arozal W, et al. Telmisartan prevents the progression of renal injury in daunorubicin rats with the alteration of angiotensin II and endothelin-1 receptor expression associated with its PPAR-γ agonist actions. Toxicology. 2011 Jan 11;279 (1-3) :91-9.|[5]Dano K, et al. Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro. Cancer Res. 1972 Jun;32 (6) :1307-14.|[6]Emeline Bollaert, et al. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin. Int J Mol Sci. 2021 May 13;22 (10) :5153. |[7]Cheng Wu, et al. Doxorubicin suppresses chondrocyte differentiation by stimulating ROS production. Eur J Pharm Sci. 2021 Dec 1;167:106013.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture and light)

Scientific Category

Natural Products

Clinical Information

Launched

Isoform

Daunorubicins/Doxorubicins; Topo II

Citation 01

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP1-97723R 0.1 mL

Mouse Monoclonal Actin Alpha 1 Skeletal Muscle Antibody (3B3) [DyLight 550]

Ask

View Details

MBS9944009 Inquire

Cavy Prolactin-Releasing Peptide (PRLH) ELISA Kit

Ask

View Details

DHD80818 100 μg

Research Grade Anti-Human CD38/ADPRC 1 (TAK-573)

Ask

View Details

D5001-1 1 Tube

CT Conversion Reagent (10 Conversions) (1 Tube)

Ask

View Details